Literature DB >> 2776898

Human chorionic gonadotropin, estradiol, and progesterone profiles in conception and nonconception cycles in an in vitro fertilization program.

K A Hutchinson-Williams1, B Lunenfeld, M P Diamond, G Lavy, S P Boyers, A H DeCherney.   

Abstract

In 22 consecutive in vitro fertilization cycles stimulated with purified follicle-stimulating hormone, human chorionic gonadotropin (hCG), estradiol (E2), and progesterone (P) were measured every 3 days during the luteal phase. All serum measurements were normalized to the day of hCG administration (day 0). There was a total of nine pregnancies; two were biochemical pregnancies, whereas 7 of the 22 women had clinical pregnancies (31.8%). Of these, two miscarried and five had term pregnancies (three singleton, two twin). Conception cycles could be differentiated from nonconception cycles by serum E2 levels on day 8 (P = 0.035), by hCG levels on day 11 (P = 0.03), and by P levels on day 14 (P = 0.001). From days 8 to 11, hCG levels plateaued in conception cycles and decreased in nonconception cycles. However, during that period, E2 and P fell in both groups of women. This decline in sex steroids, which was observed in both conception and nonconception cycles, may well negatively influence endometrial development during the peri-implantation period and compromise conception, resulting in failure to conceive, biochemical pregnancy, and early miscarriage.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2776898     DOI: 10.1016/s0015-0282(16)60915-9

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  8 in total

1.  Subpopulations of human granulosa-luteal cells obtained from gonadotropin- or gonadotropin-releasing hormone agonist/gonadotropin-treated follicles in in vitro fertilization-embryo transfer cycles.

Authors:  K Gersak; T Tomazevic
Journal:  J Assist Reprod Genet       Date:  1999-10       Impact factor: 3.412

2.  The effects of E2 supplementation from the early proliferative phase to the late secretory phase of the endometrium in hMG-stimulated IVF-ET.

Authors:  H Jung; H K Roh
Journal:  J Assist Reprod Genet       Date:  2000-01       Impact factor: 3.412

3.  Luteinizing response to human chorionic gonadotropin does not predict outcome in gonadotropin releasing hormone agonist-suppressed/human menopausal gonadotropin-stimulated in vitro fertilization (IVF) cycles.

Authors:  A S Penzias; F N Shamma; J N Gutmann; D B Seifer; A H DeCherney; G Lavy
Journal:  J Assist Reprod Genet       Date:  1992-06       Impact factor: 3.412

4.  Factors related to early pregnancy recognition in the woman.

Authors:  B Behr; B Stone; W D Foote
Journal:  J Assist Reprod Genet       Date:  1995-04       Impact factor: 3.412

5.  Human chorionic gonadotropin combined with progesterone for luteal support improves pregnancy rate in patients with low late-midluteal estradiol levels in IVF cycles.

Authors:  Akihisa Fujimoto; Yutaka Osuga; Toshihiro Fujiwara; Tetsu Yano; Osamu Tsutsumi; Mikio Momoeda; Koji Kugu; Kaori Koga; Yutaka Morita; Osamu Wada; Yuji Taketani
Journal:  J Assist Reprod Genet       Date:  2002-12       Impact factor: 3.412

6.  Assessment of the luteal phase in stimulated and substituted cycles.

Authors:  H M Fatemi
Journal:  Facts Views Vis Obgyn       Date:  2009

7.  A comparison of the effects of three luteal phase support protocols with estrogen on in vitro fertilization-embryo transfer outcomes in patients on a GnRH antagonist protocol.

Authors:  Juliano Brum Scheffer; Bruno Brum Scheffer; Rafaela Friche de Carvalho; Ana Paula Aguiar; Daniel H Mendez Lozano; Julie Labrosse; Michael Grynberg
Journal:  JBRA Assist Reprod       Date:  2019-08-22

8.  Plasmatic estradiol concentration in the mid-luteal phase is a good prognostic factor for clinical and ongoing pregnancies, during stimulated cycles of in vitro fertilization.

Authors:  Rodopiano S Florêncio; Melaynne S B Meira; Marcos V da Cunha; Mylena N C R Camarço; Eduardo C Castro; Marta C C F Finotti; Vinicius A de Oliveira
Journal:  JBRA Assist Reprod       Date:  2018-03-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.